XML 76 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Jan. 25, 2013
Jan. 27, 2012
Operating Activities:    
Net income $ 142,137 $ 142,461
Loss from discontinued operations 2 58
Adjustments to continuing operations:    
Depreciation and amortization 20,095 26,779
Deferred income taxes 7,993 (2,558)
Excess income tax benefit from share-based payment awards (1,522) (17,500)
Contributions to defined benefit employee pension plans (46,355) (45,864)
Defined benefit employee pension plan expense 6,768 14,621
Other, net (2,086) (33,755)
Changes in Working Capital Items Attributed to Continuing Operations, net of acquisition:    
Accounts receivable, net 100,405 38,988
Inventories, net (29,327) (167,210)
Other current assets (33,369) (14,862)
Trade accounts payable (56,717) (51,789)
Employee compensation and benefits (45,868) (49,804)
Advance payments and progress billings 43,812 121,894
Other accrued liabilities (13,903) 24,397
Net cash provided (used) by operating activities of continuing operations 92,065 (14,144)
Net cash used by operating activities of discontinued operations (1,571) (4,363)
Net cash provided (used) by operating activities 90,494 (18,507)
Investing Activities:    
Property, plant and equipment acquired (54,588) (49,435)
Acquisition of controlling interest in International Mining Machinery, net of cash acquired 0 (513,761)
Withdrawal of cash held in escrow 0 589,686
Other, net 2,846 151
Net cash (used) provided by investing activities (51,742) 26,641
Financing Activities:    
Share-based payment awards 4,534 19,476
Dividends paid (18,542) (18,397)
Change in short and long-term obligations, net (17,202) (10,571)
Financing fees 0 (1,628)
Net cash used by financing activities (31,210) (11,120)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (1,520) (2,089)
Increase (Decrease) in Cash and Cash Equivalents 6,022 (5,075)
Cash and Cash Equivalents at Beginning of Period 263,873 288,321
Cash and Cash Equivalents at End of Period $ 269,895 $ 283,246